Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 25
Filter
Add more filters










Publication year range
1.
Front Microbiol ; 14: 1144026, 2023.
Article in English | MEDLINE | ID: mdl-37187532

ABSTRACT

Introduction: Although severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) RNA has been frequently detected in sewage from many university dormitories to inform public health decisions during the COVID-19 pandemic, a clear understanding of SARS-CoV-2 RNA persistence in site-specific raw sewage is still lacking. To investigate the SARS-CoV-2 RNA persistence, a field trial was conducted in the University of Tennessee dormitories raw sewage, similar to municipal wastewater. Methods: The decay of enveloped SARS-CoV-2 RNA and non-enveloped Pepper mild mottle virus (PMMoV) RNA was investigated by reverse transcription-quantitative polymerase chain reaction (RT-qPCR) in raw sewage at 4°C and 20°C. Results: Temperature, followed by the concentration level of SARS-CoV-2 RNA, was the most significant factors that influenced the first-order decay rate constants (k) of SARS-CoV-2 RNA. The mean k values of SARS-CoV-2 RNA were 0.094 day-1 at 4°C and 0.261 day-1 at 20°C. At high-, medium-, and low-concentration levels of SARS-CoV-2 RNA, the mean k values were 0.367, 0.169, and 0.091 day-1, respectively. Furthermore, there was a statistical difference between the decay of enveloped SARS-CoV-2 and non-enveloped PMMoV RNA at different temperature conditions. Discussion: The first decay rates for both temperatures were statistically comparable for SARS-CoV-2 RNA, which showed sensitivity to elevated temperatures but not for PMMoV RNA. This study provides evidence for the persistence of viral RNA in site-specific raw sewage at different temperature conditions and concentration levels.

2.
Front Microbiol ; 14: 1101205, 2023.
Article in English | MEDLINE | ID: mdl-36846780

ABSTRACT

The COVID-19 pandemic brought about an urgent need to monitor the community prevalence of infection and detect the presence of SARS-CoV-2. Testing individual people is the most reliable method to measure the spread of the virus in any given community, but it is also the most expensive and time-consuming. Wastewater-based epidemiology (WBE) has been used since the 1960s when scientists implemented monitoring to measure the effectiveness of the Polio vaccine. Since then, WBE has been used to monitor populations for various pathogens, drugs, and pollutants. In August 2020, the University of Tennessee-Knoxville implemented a SARS-CoV-2 surveillance program that began with raw wastewater surveillance of the student residence buildings on campus, the results of which were shared with another lab group on campus that oversaw the pooled saliva testing of students. Sample collection began at 8 am, and the final RT-qPCR results were obtained by midnight. The previous day's results were presented to the campus administrators and the Student Health Center at 8 am the following morning. The buildings surveyed included all campus dormitories, fraternities, and sororities, 46 buildings in all representing an on-campus community of over 8,000 students. The WBE surveillance relied upon early morning "grab" samples and 24-h composite sampling. Because we only had three Hach AS950 Portable Peristaltic Sampler units, we reserved 24-h composite sampling for the dormitories with the highest population of students. Samples were pasteurized, and heavy sediment was centrifuged and filtered out, followed by a virus concentration step before RNA extraction. Each sample was tested by RT-qPCR for the presence of SARS-CoV-2, using the CDC primers for N Capsid targets N1 and N3. The subsequent pooled saliva tests from sections of each building allowed lower costs and minimized the total number of individual verification tests that needed to be analyzed by the Student Health Center. Our WBE results matched the trend of the on-campus cases reported by the student health center. The highest concentration of genomic copies detected in one sample was 5.06 × 107 copies/L. Raw wastewater-based epidemiology is an efficient, economical, fast, and non-invasive method to monitor a large community for a single pathogen or multiple pathogen targets.

3.
Microbiol Resour Announc ; 10(47): e0104921, 2021 Nov 24.
Article in English | MEDLINE | ID: mdl-34817217

ABSTRACT

Reported here is a coding-complete genome sequence of a SARS-CoV-2 variant obtained from raw wastewater samples at the University of Tennessee-Knoxville campus. This sequence provides insight into SARS-CoV-2 variants that circulate on large college campuses but remain mostly undetected.

4.
Aust Vet J ; 97(10): 401-403, 2019 Oct.
Article in English | MEDLINE | ID: mdl-31286490

ABSTRACT

Infectious Ovine Keratoconjunctivitis (IOK) is a contagious ocular disease of sheep. A range of organisms have been observed as the aetiological agents of IOK. In this study, the presence of chlamydial pathogens (C. pecorum, C. abortus, C. psittaci) in conjunctival swabs was tested for. The swabs were collected from sheep with varying grades of IOK in an Australian pre-export feedlot. The sheep had been rejected from a shipment because of the eye disease. The relative contribution of chlamydial pathogens to IOK and the rejection of animals was evaluated. In total, 149 conjunctival swabs were taken from rejected sheep (IOK Grades 1 to 6; n = 126) as well as those with healthy eyes (Grade 0; n = 23). Screening for chlamydial pathogens was done using species-specific qPCR assays. Chlamydial DNA was detected in 35.6% (53/149) of conjunctival samples. C. pecorum was the most predominant species with an overall prevalence of 28.9% (43/149). C. psittaci prevalence was 6.7% (10/149). Both organisms were detected in healthy as well as IOK-affected eyes. All swabs tested negative for C. abortus. The results from this study demonstrate that Chlamydia spp can be readily detected in sheep presenting with IOK. The zoonotic C. abortus was not detected in any of the samples in this study, providing further evidence to the suggestion that this pathogen remains absent from Australia. Although the exact contribution of Chlamydia spp in the IOK pathogenesis is unclear, such studies are anticipated to be of benefit to Australian domestic and live export production systems.


Subject(s)
Chlamydiaceae Infections/veterinary , Chlamydiaceae/isolation & purification , Eye/microbiology , Keratoconjunctivitis/veterinary , Sheep Diseases/epidemiology , Sheep Diseases/microbiology , Animals , Australia/epidemiology , Chlamydiaceae Infections/epidemiology , Keratoconjunctivitis/epidemiology , Keratoconjunctivitis/microbiology , Severity of Illness Index , Sheep
5.
J Hosp Infect ; 97(2): 133-139, 2017 Oct.
Article in English | MEDLINE | ID: mdl-28602702

ABSTRACT

BACKGROUND: Staphylococcus aureus bacteraemia (SAB) is the second most common source of positive blood cultures, after Escherichia coli, reported within NHS Scotland. Laboratory surveillance has been mandatory in Scotland for SAB since 2001. AIM: To gain an understanding of the epidemiology of SAB cases and associated risk factors for healthcare and true community onset. Identification of these factors and the patient populations at greatest risk enables the development of focused improvement plans. METHODS: All NHS boards within NHS Scotland take part in the mandatory enhanced surveillance, with data collected by trained data collectors using nationally agreed definitions. FINDINGS: Between 1st October 2014 and 31st March 2016, 2256 episodes of SAB in adults were identified. The blood cultures were taken in 58 hospitals and across all 15 Scottish health boards. The data demonstrated that approximately one-third of all SAB cases are true community cases. Vascular access devices continue to be the most reported entry point (25.7%) in individuals who receive health care, whereas skin and soft tissue risk factors are present in all origins. A significant risk factor unique to community cases is illicit drug injection. CONCLUSION: Improvement plans for reduction of SAB should be targeted more widely than hospital care settings alone.


Subject(s)
Bacteremia/microbiology , Bacteremia/mortality , Cross Infection/microbiology , Cross Infection/mortality , Staphylococcal Infections/mortality , Adolescent , Adult , Age Distribution , Aged , Aged, 80 and over , Bacteremia/epidemiology , Community-Acquired Infections/epidemiology , Community-Acquired Infections/microbiology , Cross Infection/epidemiology , Death Certificates , Equipment Contamination , Female , Hospitals , Humans , Logistic Models , Male , Methicillin-Resistant Staphylococcus aureus/isolation & purification , Middle Aged , Pediatrics , Risk Factors , Scotland/epidemiology , Sentinel Surveillance , Staphylococcal Infections/epidemiology , Staphylococcus aureus/isolation & purification , State Medicine , Young Adult
6.
J Hosp Infect ; 97(2): 127-132, 2017 Oct.
Article in English | MEDLINE | ID: mdl-28645466

ABSTRACT

BACKGROUND: National enhanced surveillance of Staphylococcus aureus bacteraemia (SAB) commenced on 1st October 2014 to gain a more in-depth understanding of the epidemiology of SAB in Scotland. Children under 16 years of age were analysed separately from adults because previous studies had demonstrated epidemiological differences. AIM: To identify risk factors and patient populations at greatest risk to enable the development of focused improvement plans. METHODS: All National Health Service (NHS) boards within NHS Scotland take part in the mandatory enhanced surveillance, with data collected by trained data collectors using nationally agreed definitions. FINDINGS: Analysis of the first 18 months of data showed that hospital-acquired SAB was mostly associated with neonates with device risk factors, whereas community-associated SAB was found in older children who had few, if any, risk factors and most presented with a bone or joint infection. CONCLUSION: The enhanced SAB data highlighted the difference in risk factors and entry points for the acquisition of SAB within the paediatric population.


Subject(s)
Bacteremia/epidemiology , Bacteremia/microbiology , Cross Infection/epidemiology , Cross Infection/microbiology , Staphylococcal Infections/epidemiology , Adolescent , Age Distribution , Bacteremia/mortality , Child , Child, Preschool , Community-Acquired Infections/epidemiology , Community-Acquired Infections/microbiology , Female , Hospitals , Humans , Infant , Logistic Models , Male , Pediatrics , Risk Factors , Scotland/epidemiology , Sentinel Surveillance , Staphylococcal Infections/mortality , Staphylococcus aureus/isolation & purification , State Medicine
7.
Lab Anim ; 47(1): 66-70, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23467491

ABSTRACT

The absorption of medetomidine released by continuous infusion from an osmotic pump in the abdominal cavity was studied in pregnant sheep during the 24 h postoperative period. Additionally pain and sedation was assessed. Eleven sheep were studied: six were treated with a medetomidine loaded osmotic pump delivering 10 µL/h (3 µg/kg/h medetomidine); and five with a saline loaded osmotic pump (control). Serial blood samples were taken and analysed to determine plasma medetomidine levels. Medetomidine was absorbed from the peritoneal cavity and a steady plasma concentration was achieved within 10 h, mean (SD) peak concentration was 2.87 (0.22) ng/mL. Sheep receiving medetomidine analgesia had significantly lower pain scores at 10 h than controls. Four control sheep required rescue analgesia, compared with 0 in the treatment group. Delivery of 3 µg/kg/h medetomidine by an intraperitoneal osmotic pump to pregnant sheep in the 24 h postoperative period provides adequate plasma concentrations of medetomidine for analgesia without sedation.


Subject(s)
Analgesia/veterinary , Analgesics, Non-Narcotic/administration & dosage , Infusions, Parenteral/veterinary , Medetomidine/administration & dosage , Pain Management/veterinary , Pain, Postoperative/drug therapy , Sheep/surgery , Analgesia/methods , Analgesics, Non-Narcotic/therapeutic use , Animals , Female , Medetomidine/therapeutic use , Pain Management/methods , Pregnancy
8.
Oral Dis ; 10(3): 155-62, 2004 May.
Article in English | MEDLINE | ID: mdl-15089925

ABSTRACT

OBJECTIVES: To isolate and characterize subgingival staphylococci from patients with periodontal disease and from periodontally healthy controls, to evaluate the periodontal environment as a potential source for systemic staphylococcal infections. METHODS: Periopaper strips were used to isolate subgingival staphylococci from 28 patients with chronic periodontitis and 28 periodontally healthy age and sex-matched controls. Staphylococci were identified by microbiological methods and antibiotic resistance profiles determined. RESULTS: Staphylococci were isolated from 54% diseased subgingival and 43% healthy subgingival sites in over 50% periodontitis patients and from 29% healthy subgingival sites in 54% controls. No significant differences in the frequency of isolation or numbers of staphylococci isolated from diseased and healthy sites were noted. Staphylococcus epidermidis was the predominant oral species. Seventy per cent (115 of 165) of all isolates were penicillin-resistant. CONCLUSIONS: Subgingival staphylococci are present in both periodontitis patients and controls. In periodontitis there is an increased risk of bacteraemia because of the increased dentogingival surface area. The dental and periodontal health of patients at risk from haematogenous infections should therefore be maintained at a high level. Antibiotic resistance profiles of the oral staphylococcal isolates suggest that amoxicillin may no longer be a suitable antibiotic for prophylaxis against systemic infections such as prosthetic valve endocarditis.


Subject(s)
Gingiva/microbiology , Periodontitis/microbiology , Staphylococcus/isolation & purification , Adult , Bacteremia/microbiology , Bacteriological Techniques , Case-Control Studies , Chronic Disease , Colony Count, Microbial , Humans , Microbial Sensitivity Tests , Middle Aged , Mouth Floor/microbiology , Palate/microbiology , Penicillin Resistance , Risk Factors , Staphylococcus/classification , Staphylococcus epidermidis/isolation & purification , Staphylococcus hominis/isolation & purification , Statistics, Nonparametric
9.
Int J Gynecol Cancer ; 13(4): 543-7, 2003.
Article in English | MEDLINE | ID: mdl-12911736

ABSTRACT

We present a case of benign mixed tumor of the vagina with its typical clinicopathologic and expanded immunohistochemical features. The strong coexpression of the mesenchymal spindle cell component with epithelial markers such as CK7, together with strong CD10, Bcl2, and estrogen and progesterone receptors favors a mullerian derived tumor. The tumor is best labeled as benign mixed mullerian tumor as originally designated.


Subject(s)
Mixed Tumor, Mullerian/pathology , Vaginal Neoplasms/pathology , Adult , Biopsy, Needle , Female , Follow-Up Studies , Gynecologic Surgical Procedures/methods , Humans , Immunohistochemistry , Mixed Tumor, Mullerian/surgery , Risk Assessment , Treatment Outcome , Vaginal Neoplasms/surgery
10.
J Clin Pathol ; 54(1): 74-5, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11271794

ABSTRACT

A case of a primary peripheral T cell lymphoma arising in the endometrium is presented. Primary lymphomas of the female genital tract are rare, with endometrial lymphomas and those of T cell type being rarer still. Extensive investigations revealed no other sites of disease and the patient was treated by hysterectomy and chemotherapy. She remains well 33 months later. We believe that this case is exceptionally unusual.


Subject(s)
Endometrial Neoplasms/pathology , Lymphoma, T-Cell, Peripheral/pathology , Female , Follow-Up Studies , Humans , Middle Aged
11.
Proc Natl Acad Sci U S A ; 97(23): 12536-40, 2000 Nov 07.
Article in English | MEDLINE | ID: mdl-11050174

ABSTRACT

Coactivators are believed to mediate estrogen-induced gene responses via interaction with estrogen receptors (ER). Currently, a major challenge is to determine the importance of each coactivator in a specific cell type and promoter context in response to a particular ligand. The potential of ER to interact with a growing list of coactivators has been shown in a variety of in vitro and gene transfer assays, yet very few data have demonstrated the interaction of endogenous coactivators with ER in intact cells. We report here a ligand-specific interaction of endogenous human ER (hER) and the AIB1 coactivator in MCF-7 human breast cancer cells by using immunoprecipitation analyses. Complexes between endogenously expressed hER and AIB1 were detected in estradiol-treated cells and to a much lesser extent in cells treated with the partial agonist, monohydroxytamoxifen. We were unable to detect an hER-SRC-1 complex in our immunoprecipitations from MCF-7 cells. The in vitro-binding affinity for mouse ER interaction with AIB1 was estimated to be 40-120 nM. We conclude that AIB1 is a major coactivator for hER in MCF-7 human breast cancer cells.


Subject(s)
Receptors, Estrogen/metabolism , Transcription Factors/metabolism , Animals , Blotting, Western/methods , Breast Neoplasms , Estradiol/metabolism , Estradiol/pharmacology , Female , Gene Expression , Histone Acetyltransferases , Humans , Mice , Nuclear Receptor Coactivator 1 , Nuclear Receptor Coactivator 3 , Precipitin Tests/methods , Receptors, Estrogen/genetics , Receptors, Steroid/metabolism , Selective Estrogen Receptor Modulators/metabolism , Selective Estrogen Receptor Modulators/pharmacology , Tamoxifen/metabolism , Tamoxifen/pharmacology , Transcription Factors/genetics , Tumor Cells, Cultured
12.
Biochemistry ; 38(22): 6987-96, 1999 Jun 01.
Article in English | MEDLINE | ID: mdl-10353810

ABSTRACT

Unoccupied estrogen receptor (ER) can be extracted from tissues by homogenization with a hypotonic buffer, whereas hormone-occupied ER becomes tightly bound to the nuclear pellet and must be extracted with high-salt-containing buffers. The molecular basis for estrogen-induced tight nuclear binding of ER remains an important puzzle. The different subcellular fractionation behaviors of the occupied and unoccupied ER are presumed to be due to a difference in their ability to interact with nuclear components, such as DNA and proteins. The proteins that are the targets for interaction with the hormone-occupied ER may be important for transcriptional regulation. However, the salt-extracted ER is recovered as a homodimer, and associated proteins are presumably lost due to the high-salt conditions. We have discovered an alternate method of releasing the occupied ER from the nucleus. Inclusion of 2 mM orthovanadate, polymerized primarily to decavanadate, in a hypotonic buffer efficiently releases over 90% of estrogen-bound ER from the nuclear pellet. The recovered ER complex is fully functional in terms of estrogen and DNA binding and is full-length by western blot analysis. Our data suggest that the mechanism of ER release is by decavanadate competition with nuclear DNA, rather than by inhibition of a phosphotyrosine phosphatase. Of particular interest, the decavanadate released occupied ER complex shows distinct behavior by sucrose density gradient sedimentation analysis. It is larger than the salt-extracted transformed ER, suggesting that an occupied ER in complex with nuclear proteins may be released from the nucleus by decavanadate.


Subject(s)
Cell Nucleus/drug effects , Cell Nucleus/metabolism , Receptors, Estrogen/metabolism , Vanadates/pharmacology , Animals , Binding, Competitive , Cell Line , Cell Nucleus/enzymology , Centrifugation, Density Gradient , DNA/drug effects , DNA/metabolism , Dose-Response Relationship, Drug , Humans , Ligands , Macromolecular Substances , Mice , Phosphoprotein Phosphatases/antagonists & inhibitors , Protein Binding/drug effects , Rats , Receptors, Estrogen/chemistry , Receptors, Estrogen/physiology , Salts , Tromethamine , Tumor Cells, Cultured , Vanadates/chemistry
13.
Biochemistry ; 34(28): 9144-50, 1995 Jul 18.
Article in English | MEDLINE | ID: mdl-7619813

ABSTRACT

The estrogen receptor (ER) binds with high affinity to the nonclassical estrogen response elements (ERE) found in the rat prolactin gene. There are two putative EREs in this gene; at -1582 and -1722 upstream of the transcriptional start site. We used DNA binding assays based on the immunoprecipitation of receptor with bound DNA to quantitate the binding of ER to these two elements. ER bound each element with significantly higher affinity than it bound to nonspecific DNA, but with 10-100-fold less affinity than that for the classical ERE sequence derived from the vitellogenin A2 gene. These comparisons rank the prolactin gene sequences as weak EREs. We also observed a 1:1 ratio of ER to ERE in the bound complexes, indicating that these high-affinity interactions were not dependent upon an ER homodimer. These data support the role of these sequences in mediating estrogen regulation of the prolactin gene.


Subject(s)
DNA/genetics , DNA/metabolism , Prolactin/genetics , Receptors, Estrogen/metabolism , Animals , Base Sequence , Binding Sites/genetics , Binding, Competitive , Cytosol/metabolism , Female , In Vitro Techniques , Kinetics , Molecular Sequence Data , Protein Binding , Rats , Rats, Sprague-Dawley , Thermodynamics , Uterus/metabolism , Vitellogenins/genetics
15.
J Biol Chem ; 268(17): 12519-25, 1993 Jun 15.
Article in English | MEDLINE | ID: mdl-8509392

ABSTRACT

We have developed an antibody-based DNA binding assay to study the effects of the absence or presence of an estrogen receptor agonist and two antagonists on the thermodynamic binding parameters for estrogen receptor binding to a consensus estrogen response element in vitro. We first demonstrate that antibodies raised against a region of the estrogen receptor directly adjacent to the DNA-binding domain do not interfere with the receptor's ability to preferentially bind to the vitellogenin estrogen response element in plasmid DNA. Exploiting this property to develop a quantitative DNA binding assay, we demonstrate that estrogen is not required for high affinity binding of the receptor for an oligonucleotide containing this element, nor do antiestrogens alter this interaction. In addition, we find that 1 mol of estrogen receptor is complexed with high affinity to 1 mol of vitellogenin estrogen response element, instead of two estrogen receptors/response element as would be predicted if estrogen receptor homodimer formation was required for high affinity DNA binding. Our data best fit a model in which the active estrogen receptor form is a monomer or heterodimer, but not a homodimer, and the regulatory role of estrogen on the estrogen receptor is the induction of protein-protein, but not protein-DNA, interactions.


Subject(s)
DNA-Binding Proteins/metabolism , DNA/metabolism , Estradiol/metabolism , Estrogen Antagonists/metabolism , Oligodeoxyribonucleotides/metabolism , Receptors, Estrogen/metabolism , Uterus/metabolism , Animals , Antibodies , Base Sequence , Cytosol/metabolism , DNA-Binding Proteins/isolation & purification , Estradiol/analogs & derivatives , Estradiol/pharmacology , Estrogen Antagonists/pharmacology , Female , Kinetics , Macromolecular Substances , Molecular Sequence Data , Oligodeoxyribonucleotides/chemical synthesis , Polyunsaturated Alkamides , Rats , Rats, Sprague-Dawley , Receptors, Estrogen/isolation & purification , Restriction Mapping , Tamoxifen/analogs & derivatives , Tamoxifen/metabolism , Tamoxifen/pharmacology , Thermodynamics
16.
Biol Reprod ; 48(1): 8-14, 1993 Jan.
Article in English | MEDLINE | ID: mdl-8418919

ABSTRACT

Estrogen receptors are key elements in the mechanisms of action of estrogenic hormones. Models of how estrogens and their receptors interact and subsequently modify gene expression should be reevaluated to explain new data currently available. The following review discusses nuclear localization, DNA binding, and protein structural changes of the estrogen receptor induced by estrogen binding. We also discuss how these phenomena relate to the induction of changes in gene expression.


Subject(s)
Gene Expression Regulation , Models, Biological , Receptors, Estrogen/metabolism , Animals , DNA/metabolism , Estrogens/metabolism , Estrogens/pharmacology , Female , Gene Expression Regulation/drug effects , Humans , Rats , Receptors, Estrogen/drug effects
18.
J Biol Chem ; 267(3): 1823-8, 1992 Jan 25.
Article in English | MEDLINE | ID: mdl-1730720

ABSTRACT

The ability of DNA to allosterically alter the conformation of the estrogen receptor's (ER) steroid binding domain was investigated. Using dissociation kinetics we observed that when DNA was bound to the DNA binding domain of the rat uterine ER the rate of estrogen dissociation from the steroid binding domain increased almost 2-fold. This change in the rate of estrogen dissociation depended on the concentration of DNA used and correlated with the thermodynamic binding affinities (Kd) of the ER for two different DNA sequences. We were unable to detect a DNA-induced change in the trypsin cleavage pattern of the amino terminal end of the ER. Using a whole cell dissociation kinetic assay with MCF-7 breast cancer cells we observed a 7-fold slower rate of estrogen dissociation from the ER within the cell than from the ER in vitro. This suggests that additional factors, other than DNA binding, may modify the steroid binding domain within the cell. We conclude that DNA can allosterically modulate the structure of the steroid binding domain of the ER, and we hypothesize that this conformational change may be necessary for the full transcriptional activity of the ER.


Subject(s)
DNA/metabolism , Oligodeoxyribonucleotides/metabolism , Receptors, Estrogen/metabolism , Uterus/metabolism , Allosteric Regulation , Animals , Base Sequence , Binding Sites , Breast Neoplasms , Cell Line , Cytosol/metabolism , Female , Humans , Immunoblotting , Kinetics , Molecular Sequence Data , Oligodeoxyribonucleotides/chemical synthesis , Protein Conformation , Rats , Rats, Inbred Strains , Receptors, Estrogen/isolation & purification
19.
Biochemistry ; 30(45): 10838-44, 1991 Nov 12.
Article in English | MEDLINE | ID: mdl-1932006

ABSTRACT

Avidin-biotin complexed with DNA (ABCD) assays were employed to determine the binding affinity of estrogen receptor (ER) to DNA under various salt conditions. Type and concentration of salt in the reaction buffer dramatically affected the ability of the ER to discriminate between DNA sequences. Under appropriate salt conditions, ER was able to bind to the estrogen response element from the Xenopus vitellogenin A2 gene with at least 3 orders of magnitude greater affinity than a two base pair mutant sequence, and 5 orders of magnitude greater affinity than plasmid DNA. In these studies, the best discrimination was observed under conditions of salt type and concentration that more closely approximated intracellular conditions, i.e., 100-150 mM potassium salts. Analysis of the binding affinities for ER to all three types of DNA over a range of KCl concentrations indicated that the ionic interactions upon ER binding were the same for the three DNA molecules tested. Therefore, the additional stability of ER binding to target DNA sequences was contributed by nonionic interactions.


Subject(s)
DNA/metabolism , Genes , Receptors, Estrogen/metabolism , Salts/pharmacology , Vitellogenins/genetics , Animals , Base Sequence , Binding, Competitive , Cytosol/metabolism , Female , Kinetics , Molecular Sequence Data , Osmolar Concentration , Potassium Chloride/pharmacology , Protein Binding , Rats , Rats, Inbred Strains , Xenopus
20.
Mol Cell Endocrinol ; 78(3): C103-8, 1991 Jul.
Article in English | MEDLINE | ID: mdl-1778298

ABSTRACT

We believe that steroid binding is not required for receptor binding to DNA, but instead induces a conformational change in the receptor domains involved in the protein-protein interactions proposed above. Data from Hansen and Gorski (1986), and more recent studies (M. Fritsch and J. Gorski, unpublished results) strongly suggest that the steroid binding domain when bound to estrogens undergoes a dramatic change in conformation characterized by a loss of hydrophobic surface. This marked change in the steroid binding domain probably affects the so-called dimerization region located in this domain and thus the interaction of receptor with nuclear proteins in vivo. In our working model, ER is bound to specific DNA sequences or response elements of a variety of genes with or without estrogen. Ligand binding induces conformational changes in the steroid binding and perhaps other domains of the receptor that in turn change receptor interaction with the transcriptional machinery. The nature of this change is not at all clear at present, and the possibility of enzymatic modification of receptor or associated transcription factors should not be excluded. Whatever the mechanism of receptor action on transcription, we expect it kinetically will be closely related to the occupancy of the receptor with estrogen. Finally, any model of ER interactions with target genes also needs to account for the drastic ligand effect on the extractability of all ER from the nucleus.


Subject(s)
Gene Expression Regulation , Receptors, Estrogen/metabolism , Cell Nucleus/metabolism , DNA/metabolism , Estrogens/metabolism , Heat-Shock Proteins/physiology , Nuclear Proteins/metabolism , Regulatory Sequences, Nucleic Acid , Transcription, Genetic
SELECTION OF CITATIONS
SEARCH DETAIL
...